指南与共识儿科与产科急症重症综合管理与镇静镇痛

预防性环氧合酶抑制剂用于预防极早产儿发病与死亡的临床实践指南:纳入家庭价值观与偏好

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in extremely preterm infants: a clinical practice guideline incorporating family values and preferences.
指南 / 共识 · Arch Dis Child Fetal Neonatal Ed · 2024-04-18
一句话结论极早产儿可考虑预防性静脉吲哚美辛(条件推荐,中等确定性),不常规用布洛芬(条件推荐,低确定性),强烈不推荐预防性对乙酰氨基酚(强推荐,极低确定性)。

该指南由12人小组(含5名新生儿医护人员、2名方法学专家、1名药师、2名极早产儿父母和2名极早产成人)制定,采用GRADE证据到决策框架进行多比较,基于Cochrane网状Meta分析和家庭价值观与偏好混合方法研究。推荐极早产儿(胎龄≤28周)可考虑预防性静脉吲哚美辛(条件推荐,中等确定性),用药前与家长共享决策;不推荐常规预防性使用布洛芬(条件推荐,低确定性);强烈不推荐预防性使用对乙酰氨基酚(强推荐,极低确定性),直至有进一步研究证据。

要点

  • 极早产儿(胎龄≤28周)可考虑预防性静脉吲哚美辛(条件推荐,中等确定性)。
  • 用药前应与家长共享决策,评估其价值观与偏好(指南推荐)。
  • 不推荐在该胎龄组常规预防性使用布洛芬(条件推荐,低确定性)。
  • 强烈不推荐预防性使用对乙酰氨基酚(强推荐,极低确定性),直至有进一步研究证据。

适用人群与场景

  • 极早产儿(胎龄≤28周)。

处置流程与药物剂量

  • 对极早产儿可考虑预防性静脉使用吲哚美辛(条件推荐,中等确定性);用药前与家长共享决策,评估其价值观与偏好。
  • 不推荐对极早产儿常规预防性使用布洛芬(条件推荐,低确定性)。
  • 强烈不推荐预防性使用对乙酰氨基酚(强推荐,极低确定性),直至有进一步研究证据。

研究设计与关键结果

  • 指南制定小组共12人,包括5名有经验的新生儿照护提供者、2名方法学专家、1名药师、2名极早产儿父母和2名极早产成人。
  • 采用GRADE证据到决策框架进行多比较,预先设定最重要的临床结局,主要证据来源为Cochrane网状Meta分析和一项探索家庭价值观与偏好的横断面混合方法研究。

证据类型、等级与局限

  • 证据类型:临床实践指南,采用GRADE证据到决策框架。
  • 推荐强度与证据确定性:预防性静脉吲哚美辛为条件推荐、中等确定性;不常规用布洛芬为条件推荐、低确定性;不预防性用对乙酰氨基酚为强推荐、极低确定性。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对极早产儿(胎龄≤28周),临床医生可考虑预防性静脉使用吲哚美辛(条件推荐,中等确定性),并与家长共享决策。
  • 不推荐对极早产儿常规预防性使用布洛芬(条件推荐,低确定性)。
  • 强烈不推荐预防性使用对乙酰氨基酚(强推荐,极低确定性),直至有进一步研究证据。

指南或共识出处

  • 临床实践指南(Arch Dis Child Fetal Neonatal Ed)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

ImportanceProphylactic cyclo-oxygenase inhibitors (COX-Is) such as indomethacin, ibuprofen and acetaminophen may prevent morbidity and mortality in extremely preterm infants (born ≤28 weeks' gestation). However, there is controversy around which COX-I, if any, is the most effective and safest, which has resulted in considerable variability in clinical practice. Our objective was to develop rigorous and transparent clinical practice guideline recommendations for the prophylactic use of COX-I drugs for the prevention of mortality and morbidity in extremely preterm infants. The Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework for multiple comparisons was used to develop the guideline recommendations. A 12-member panel, including 5 experienced neonatal care providers, 2 methods experts, 1 pharmacist, 2 parents of former extremely preterm infants and 2 adults born extremely preterm, was convened. A rating of the most important clinical outcomes was established a priori. Evidence from a Cochrane network meta-analysis and a cross-sectional mixed-methods study exploring family values and preferences were used as the primary sources of evidence. The panel recommended that prophylaxis with intravenous indomethacin may be considered in extremely preterm infants (conditional recommendation, moderate certainty in estimate of effects). Shared decision making with parents was encouraged to evaluate their values and preferences prior to therapy. The panel recommended against routine use of ibuprofen prophylaxis in this gestational age group (conditional recommendation, low certainty in the estimate of effects). The panel strongly recommended against use of prophylactic acetaminophen (strong recommendation, very low certainty in estimate of effects) until further research evidence is available.

来源:Arch Dis Child Fetal Neonatal Ed,查看原文。版权归原作者所有。

参考来源

  1. Mitra S, Whitehead L, Smith K, et al. Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in extremely preterm infants: a clinical practice guideline incorporating family values and preferences. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 37419686. doi:10.1136/archdischild-2023-325445

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。